Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 9Lung Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Motor Activity 2Colorectal Neoplasms 2Anxiety Disorders 2Sarcopenia 1Resectable Lung Non-Small Cell Carcinoma 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Parasomnias 1Panic Disorder 1Pancreatic Neoplasms 1Liver Neoplasms 1Fatigue 1Emotional Regulation 1Depression 1Colonic Neoplasms 1Caregivers With a Child Followed up With a Cancer Diagnosis 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Relaxation Therapy × Clear all
NCT00735618 2011-12-19

Relaxation and Heart Rate Variability

M.D. Anderson Cancer Center

Phase NA Completed
20 enrolled 3 charts

Anxiety Disorders, Neoplasms, Panic Disorder

NCT00435474 2009-06-09

Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy

Rigshospitalet, Denmark

Phase 3 Completed
70 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡